Institutional investors purchased a net $68.1 million shares of GILD during the quarter ended March 2016 and now own 83.01% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Biotechnology industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
JPMORGAN INVESTMENT MANAGEMENT, ... Bought 3.6 Million shares of Gilead Sciences
INVESTEC ASSET MANAGEMENT LTD. Bought 3.1 Million shares of Gilead Sciences
BARCLAYS CAPITAL, INC. Bought 2.7 Million shares of Gilead Sciences